Endotag Medical

At Manningham Medical Centre, you can find all the data about Endotag Medical. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

EndoTAG™-1 Shows Promise in Treatment of …

https://news.cancerconnect.com/pancreatic-cancer/endotag-1-shows-promise-in-treatment-of-pancreatic-cancer

To evaluate EndoTAG™-1 in the treatment of pancreatic cancer, researchers conducted a Phase II clinical trial among 200 patients with inoperable, locally advanced or metastatic pancreatic …

EndoTAG-1 plus gemcitabine versus gemcitabine alone in …

https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS4669

EndoTAG-1 is a novel formulation of cationic liposomes embedded with Paclitaxel, which specifically displays antivascular and antiangiogenic activities. By …

SynCore Biotechnology Announces Interim Analysis Results for …

https://www.syncorebio.com/en/syncore-biotechnology-announces-interim-analysis-results-for-novel-pancreatic-cancer-asset-sb05pc-endotag-1/

EndoTAG ®-1 is a novel pancreatic cancer drug, a cationic liposomal paclitaxel, with EMA and US FDA orphan drug designations. The global phase III clinical trial is …

Multiple endocrine neoplasia, type 1 (MEN 1) - Mayo Clinic

https://www.mayoclinic.org/diseases-conditions/men-1/symptoms-causes/syc-20353064

Multiple endocrine neoplasia, type 1 (MEN 1), sometimes called Wermer's syndrome, is a rare disorder that causes tumors in the endocrine glands and parts …

SB05PC (EndoTAG®-1) Phase III been Approved in China by …

https://www.syncorebio.com/en/sb05pc-endotag-1-phase-iii-been-approved-in-china-by-nmpa/

China NMPA Approves SynCore Biotechnology to Conduct Phase III Human Clinical Trial for SB05PC (EndoTAG®-1), A First-Line Therapy for Pancreatic Cancer. …

MediGene reports additional phase II results of …

https://www.medigene.com/fileadmin/news-feedcache/1426832/release_1426832.pdf

The trial objective of evaluating efficacy of EndoTAG. TM-1 was achieved by the combination therapy with Paclitaxel. Primary endpoint: The primary endpoint was a progression-free …

EndoTAG-1. MediGene - PubMed

https://pubmed.ncbi.nlm.nih.gov/16370392/

MediGene is developing EndoTAG-1, a formulation of paclitaxel encapsulated in positively charged lipid-based complexes, for the potential treatment of cancer. Phase II clinical …

EndoTAG1 - Lymph Nodes - 78 Steps Health

https://www.78stepshealth.us/lymph-nodes/endotag1.html

EndoTAG®-1, which is currently tested in clinical studies, comprises about 3 mol% paclitaxel in a DOTAP/DOPC lipid matrix. For application to a patient it is present …

Cationic liposomal paclitaxel plus gemcitabine or …

https://pubmed.ncbi.nlm.nih.gov/21896540/

Background: Paclitaxel embedded in cationic liposomes (EndoTAG™-1; ET) is an innovative agent targeting tumor endothelial cells. This randomized controlled …

Endotag Medical | Day of Difference

https://dayofdifference.org.au/e-medical/endotag-medical.html

All information about Endotag Medical At dayofdifference.org.au you will find all the information about Endotag Medical. We have collected a lot of medical information. …

Need more information about Endotag Medical?

At Manningham Medical Centre, we collected data on more than just Endotag Medical. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.